China · Delayed Price · Currency is CNY Jiangsu CoWin Biotech Statistics
Total Valuation
SHA:688426 has a market cap or net worth of CNY 2.34 billion. The enterprise value is 1.63 billion.
| Market Cap | 2.34B |
| Enterprise Value | 1.63B |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688426 has 109.93 million shares outstanding. The number of shares has decreased by -0.89% in one year.
| Current Share Class | 109.93M |
| Shares Outstanding | 109.93M |
| Shares Change (YoY) | -0.89% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 8.06% |
| Float | 34.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.65 |
| PB Ratio | 1.76 |
| P/TBV Ratio | 1.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.79, with a Debt / Equity ratio of 0.03.
| Current Ratio | 14.79 |
| Quick Ratio | 13.61 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.63 |
| Interest Coverage | -107.00 |
Financial Efficiency
Return on equity (ROE) is -6.58% and return on invested capital (ROIC) is -16.63%.
| Return on Equity (ROE) | -6.58% |
| Return on Assets (ROA) | -4.22% |
| Return on Invested Capital (ROIC) | -16.63% |
| Return on Capital Employed (ROCE) | -7.25% |
| Weighted Average Cost of Capital (WACC) | 8.47% |
| Revenue Per Employee | 285,333 |
| Profits Per Employee | -112,726 |
| Employee Count | 769 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 2.47 |
Taxes
In the past 12 months, SHA:688426 has paid 5.89 million in taxes.
| Income Tax | 5.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.77% in the last 52 weeks. The beta is 0.79, so SHA:688426's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -7.77% |
| 50-Day Moving Average | 18.27 |
| 200-Day Moving Average | 22.07 |
| Relative Strength Index (RSI) | 61.83 |
| Average Volume (20 Days) | 2,195,214 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688426 had revenue of CNY 219.42 million and -86.69 million in losses. Loss per share was -0.79.
| Revenue | 219.42M |
| Gross Profit | 93.53M |
| Operating Income | -103.37M |
| Pretax Income | -84.67M |
| Net Income | -86.69M |
| EBITDA | -73.74M |
| EBIT | -103.37M |
| Loss Per Share | -0.79 |
Balance Sheet
The company has 756.03 million in cash and 43.35 million in debt, with a net cash position of 712.69 million or 6.48 per share.
| Cash & Cash Equivalents | 756.03M |
| Total Debt | 43.35M |
| Net Cash | 712.69M |
| Net Cash Per Share | 6.48 |
| Equity (Book Value) | 1.33B |
| Book Value Per Share | 11.96 |
| Working Capital | 840.78M |
Cash Flow
In the last 12 months, operating cash flow was -37.73 million and capital expenditures -31.04 million, giving a free cash flow of -68.76 million.
| Operating Cash Flow | -37.73M |
| Capital Expenditures | -31.04M |
| Depreciation & Amortization | 29.63M |
| Net Borrowing | -23.73M |
| Free Cash Flow | -68.76M |
| FCF Per Share | -0.63 |
Margins
Gross margin is 42.62%, with operating and profit margins of -47.11% and -39.51%.
| Gross Margin | 42.62% |
| Operating Margin | -47.11% |
| Pretax Margin | -38.59% |
| Profit Margin | -39.51% |
| EBITDA Margin | -33.61% |
| EBIT Margin | -47.11% |
| FCF Margin | n/a |
Dividends & Yields
SHA:688426 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.89% |
| Shareholder Yield | 0.89% |
| Earnings Yield | -3.71% |
| FCF Yield | -2.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 12, 2023. It was a forward split with a ratio of 1.2000048.
| Last Split Date | Jun 12, 2023 |
| Split Type | Forward |
| Split Ratio | 1.2000048 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |